Neue HER2-zielgerichtete Therapieoption für vorbehandelte Patientinnen mit metastasiertem Mammakarzinom

Translated title of the contribution: A new HER2-targeted therapeutic option for pretreated patients with metastatic breast cancer

M. Banys-Paluchowski*

*Corresponding author for this work
    Translated title of the contributionA new HER2-targeted therapeutic option for pretreated patients with metastatic breast cancer
    Original languageGerman
    JournalOnkologe
    Volume26
    Issue number6
    Pages (from-to)561-563
    Number of pages3
    ISSN0947-8965
    DOIs
    Publication statusPublished - 01.06.2020

    Research Areas and Centers

    • Research Area: Luebeck Integrated Oncology Network (LION)
    • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    • SDG 3 - Good Health and Well-being

    Access to Document

    Other files and links

    Cite this